G1 Therapeutics Inc. (GTHX:NASDAQ) began two Phase Two clinical trials of Cosela (trilaciclib) in patients with early-stage triple negative breast cancer (TNBC), H.C. Wainwright & Co. analyst Edwar...
- 8 MIN READ
- 12/06/2021
© 2022 Equities News | Equities.com, Inc.